Active surveillance for low-risk prostate cancer: knowledge, acceptance and practice among urologists
- 6 December 2011
- journal article
- Published by Springer Science and Business Media LLC in Prostate Cancer and Prostatic Diseases
- Vol. 15 (2), 177-181
- https://doi.org/10.1038/pcan.2011.57
Abstract
Background: This study aimed to survey urologists regarding their knowledge, acceptance and practice of active surveillance (AS) for low-risk prostate cancer. Methods: An email-based survey was distributed to 4987 urologists. Respondents were surveyed regarding their knowledge and acceptance of AS. Those who felt AS was a reasonable strategy were asked their opinions on the criteria for AS enrollment and the details of their practice of AS. Respondents who felt AS was not a reasonable alternative were queried as to the reasons why. Results: A total of 425 (9%) urologists successfully completed the survey and 387 (91%) were both familiar with AS and aware that AS differed from watchful waiting. Of this latter group, 370 (96%) respondents felt AS was a reasonable management strategy, 95% of whom manage patients with this approach. A minority of respondents (6%) felt that patients with a PSA>10 ng ml−1 were eligible for AS. Further, most participants (74%) felt that patients required a Gleason score ⩽6. There was little agreement on the timing of follow-up biopsies. Respondents who objected to AS were most commonly concerned with missing an opportunity for curative treatment (76%) and the risk of tumor undergrading (65%). Conclusions: The majority of participants were knowledgeable and accepting of AS. Respondents were in relative agreement regarding the PSA and Gleason score criteria for AS enrollment. In contrast, there was a lack of agreement on the timing of follow-up biopsies. In the future, comparative studies are required to determine the optimal enrollment criteria and follow-up protocol for patients managed with AS.Keywords
This publication has 25 references indexed in Scilit:
- The Contemporary Concept of Significant Versus Insignificant Prostate CancerEuropean Urology, 2011
- Active surveillance for low-risk prostate cancer: an updateNature Reviews Urology, 2011
- EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised DiseaseEuropean Urology, 2011
- MRI for men undergoing active surveillance or with rising PSA and negative biopsiesNature Reviews Urology, 2010
- Disease insight and treatment perception of men on active surveillance for early prostate cancerBJU International, 2010
- UROSEPSIS AND BACTERAEMIA CAUSED BY ANTIBIOTIC-RESISTANT ORGANISMS AFTER TRANSRECTAL ULTRASONOGRAPHY-GUIDED PROSTATE BIOPSYBJU International, 2009
- Factors Influencing Men Undertaking Active Surveillance for the Management of Low-Risk Prostate CancerOncology Nursing Forum, 2009
- Internet Survey of Management Trends of Urethral StricturesUrologia Internationalis, 2008
- Prospective Evaluation of Selection Criteria for Active Surveillance in Japanese Patients with Stage T1cN0M0 Prostate CancerJapanese Journal of Clinical Oncology, 2008
- Guideline for the Management of Clinically Localized Prostate Cancer: 2007 UpdateJournal of Urology, 2007